ARE LIPOPROTEIN PROFILE AND LIPOPROTEIN (A) LEVELS ALTERED IN MEN WITH PSORIASIS

Citation
D. Seckin et al., ARE LIPOPROTEIN PROFILE AND LIPOPROTEIN (A) LEVELS ALTERED IN MEN WITH PSORIASIS, Journal of the American Academy of Dermatology, 31(3), 1994, pp. 445-449
Citations number
46
Categorie Soggetti
Dermatology & Venereal Diseases
ISSN journal
01909622
Volume
31
Issue
3
Year of publication
1994
Part
1
Pages
445 - 449
Database
ISI
SICI code
0190-9622(1994)31:3<445:ALPAL(>2.0.ZU;2-5
Abstract
Background: Previous studies have demonstrated that patients with psor iasis may have an increased risk of a variety of noncutaneous diseases , including arterial and venous occlusive diseases. Changes in plasma lipid and lipoprotein composition in patients with psoriasis may be th e reason for the increased risk of atherosclerosis in these patients. Lipoprotein (a) (Lp(a)) is a genetically determined lipoprotein associ ated with an increased prevalence of atherosclerotic and thrombotic ca rdiovascular diseases. Objective: The aim of this prospective study wa s to determine the lipid profile and to define the significance of Lp( a) levels in men with psoriasis. The other purpose was to learn whethe r a correlation exists between psoriasis area and severity index score and serum Lp(a) or other lipids. Methods: Serum Lp(a) levels were mea sured with a commercially available noncompetitive enzyme-linked immun osorbent assay in 32 men with psoriasis and in 13 healthy men. Total s erum cholesterol, triglyceride, high-density lipoprotein, low-density lipoprotein, apolipoprotein A-I and apolipoprotein B levels, and ather osclerotic risk factors other than hyperlipidemia were determined. Sec ondary hyperlipidemia from various diseases and drugs was ruled out in both groups. Results: Serum Lp(a) levels were higher in men with psor iasis than in healthy male subjects, but the difference was not signif icant (p = 0.063). Serum fasting glucose levels were also found to be higher in the psoriasis group (p < 0.05). Higher serum Lp(a) and fasti ng glucose levels tended to occur in patients with extensive and sever e skin involvement. No statistical differences were observed in the to tal cholesterol, triglyceride, high-density lipoprotein, low-density l ipoprotein, apolipoprotein A-I, and apolipoprotein B levels between th e two groups (p > 0.05). Conclusion: Our results suggest that the incr eased Lp(a) level might be a factor involved in occlusive vascular dis orders in patients with psoriasis and that patients with extensive and se were skin involvement are more predisposed to relatively high Lp(a ) levels.